Ascentage Pharma Group International Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-428.00
-1,031.00
-1,031.00
-1,003.00
-758.00
-1,680.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
120.00
-1.00
97.00
280.00
-44.00
26.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-186.00
-895.00
-842.00
-697.00
-682.00
-512.00
Cash Flow from Investing Activities
-392.00
35.00
-447.00
-562.00
-120.00
-228.00
Cash Flow from Financing Activities
406.00
498.00
778.00
2,167.00
1,175.00
506.00
Net Cash Inflow / Outflow
-157.00
-331.00
-443.00
879.00
325.00
-233.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
14.00
30.00
67.00
-28.00
-46.00
1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Ascentage Pharma Group International Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-428.240227969329
180.351962409865
-608.00
-337.45%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
120.416068396223
14.2228483659726
106.00
746.64%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-186.288087947576
293.904893883036
-479.00
-163.38%
Cash Flow from Investing Activities
-392.526978821077
-174.444026692059
-218.00
-125.02%
Cash Flow from Financing Activities
406.934145240275
-97.2906580594465
503.00
518.27%
Net Cash Inflow / Outflow
-157.051992034446
28.3351059000097
-185.00
-654.27%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
14.8289294939325
6.16489676847996
8.00
140.54%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 79.20% vs -6.36% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-186.29
-895.59
79.20%






